Broadly Acting Antibodies in Blood of Ebola Survivors Offer Ample Protection Against Disease
Scientists supported by the NIAID discover a set of broadly neutralizing antibodies in the blood of Ebola survivors capable of providing substantial protection against the disease.
Five Action Steps to Integrate Treatment of Opioid Use Disorder & Infectious Disease Epidemics
National Academies of Sciences, Engineering, and Medicine workshop highlights 5 key calls for action geared at health providers responsible for treating the infectious complications of patients with opioid use disorder.
Sepsis–Cancer Link Further Supported by National Cancer Institute Study
The results indicate a significant link between sepsis and 15 cancers in elderly patients.
Hepatitis A Outbreaks Continue to Grow in Multiple States
Hepatitis A outbreaks that have been crippling states across the nation since March of 2017 continue to wreak havoc in several cities.
Ebola Outbreak Reportedly Contained Following Implementation of Vaccine
There have been no confirmed cases of Ebola in the Democratic Republic of the Congo since June 6.
Another Adverse Effect of the Opioid Epidemic: Hepatitis C Infections
An increase in injection drug use in the United States has augmented the likelihood of acquiring HCV, particularly genotype 3.
FDA Files Complaint Against Company Selling Unapproved Antiseptics Claiming to Prevent Infections
The FDA seeks a permanent injunction against a company selling unapproved hand sanitizers that claim to be effective against infections from several pathogens.
New Technology Platform Delivers Single-Dose Vaccines Targeting Multiple Viruses
Single-dose vaccines delivered via a new technology platform may offer full protection against Zika, Lassa fever, and Ebola.
Top Infectious Disease News of the Week—June 3, 2018
Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.
New Testing & Disease Management Guidelines for Hepatitis C Virus Infections in Unique Populations
The new guidelines include updates on HCV management and testing in pregnant women, individuals who inject drugs, men who have sex with men, and individuals who are incarcerated.
FDA Grants Market Clearance to Rapid Sepsis Test
The FDA has provided marketing clearance for a device capable of detecting specific sepsis-causing bacterial pathogens directly from a whole blood specimen in about 5 hours.
Sepsis Treatment Through Outpatient Follow-Up Yields Positive Outcomes in Some Patients
A new study finds that some patients with sepsis who are discharged after initial treatment, and then seen through outpatient follow-up still have positive outcomes.
IV Contrast Media Does Not Raise the Risk of AKI in Sepsis Patients
In sepsis patients undergoing CT imaging, contrast media administered intravenously does not significantly raise the risk of acute kidney infection.
Top 5 Infectious Disease News of the Week—May 13, 2018
In case you missed them, we've compiled the top five infectious disease articles from this past week.
Hepatitis A Running Rampant Throughout the United States
Two more states have reported hepatitis A outbreaks since our last update—here’s what you should know about them.
HIV's Ancient Cousin, HTLV-1, Surging Through Indigenous Australian Communities
Rates of a lesser known virus related to HIV called HTLV-1 have surged in some of Australia’s Aboriginal communities, and now the country’s health officials are facing a global outcry to act.
Proposed Budget Cuts to Global Health Might Be Bad Medicine for State Economies: Public Health Watch Report
A new report by Global Health Technologies Coalition assesses the economic impact of cuts to global health R&D on the economies of US states.
Single-Dose Of Ebola Vaccine May Provide Protection Against Deadly Disease for Up to 2 Years
A recent study has found that a single-dose of Merck's Ebola vaccine delivers antibodies that can last for 1 to 2 years.
Researchers Pinpoint Cause of Candida auris Outbreak in the United Kingdom
An outbreak of infections caused by the drug-resistant fungus, Candida auris, in one United Kingdom hospital has been linked to multi-use patient equipment.
Understanding Infectious Disease Risks Associated with Drug Diversion & How to Prevent Events
If there are controlled substances at your facility, diversion is happening. What can be done to prevent future events?
Preliminary Case Series Provides Snapshot of Hepatitis A Outbreak in Michigan
Researchers present preliminary case series of confirmed cases of hepatitis A virus at Detroit Medical Center as Michigan struggles with ongoing outbreak.
Endocarditis Joins HIV and Hepatitis Among Infections Related to Opioid Epidemic: Public Health Watch
Infections associated with the ongoing opioid epidemic in the United States apparently know no bounds.
Researchers Identify Mechanism That May Lead to Age Disparity in Chronic HBV
Researchers have identified the OX40 pathway as playing a key role in viral clearance.
Treating Hepatitis C Virus and HIV Coinfections in Intravenous Drug Users
Unique considerations are called for when caring for intravenous drug users with newly diagnosed HIV/HCV coinfections.
When Invasive Meningococcal Disease Presents Abdominally
Invasive meningococcal disease doesn’t always present with the classic symptoms of stiff neck and headache—for a small subset of IMD patients, the abdomen is where the disease shows itself.
Hospital Patients in Colorado at Risk of Hepatitis & HIV Following Surgery
The risk comes after it was found that surgical instruments used for orthopedic and spine surgeries were not cleaned properly and consequently, the sterilization of those instruments was compromised.
CDC's Uganda-Based Viral Surveillance Program Significantly Reduces Disease Detection Time
The program can detect viral hemorrhagic fevers about 12 days faster than previous efforts.
Global Virome Project Will Spend Next 10 Years Identifying Unknown Viruses in the Wild
The Global Virome Project is set to launch in 2018, and will spend the next 10 years working to identify as many as 827,000 unknown viruses in the wild.
Classes and Agents Available to Treat <i>Pseudomonas</i> Infections
Fighting <i>Pseudomonas</i>: Impact On Patient Prognosis & Approaches to Combat Infection
2 Clarke Drive Cranbury, NJ 08512